Alia Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $4.9M

  • Investors
  • 7

Alia Therapeutics General Information

Description

Developer of gene-editing therapies designed to address genetic diseases. The company utilizes a proprietary prediction algorithm and an evolution platform to engineer novel nucleases, providing biotechnology companies with therapeutic co-development and technology licensing to enable precise treatments for inherited disorders.

Contact Information

Website
www.aliatherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Viale dell'Industria, 45
  • Pergine Valsugana(Trentino)
  • Italy
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Viale dell'Industria, 45
  • Pergine Valsugana(Trentino)
  • Italy

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alia Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 17-Apr-2023 $4.9M Completed Generating Revenue
3. Seed Round 28-May-2021 Completed Generating Revenue
2. Seed Round 08-Apr-2019 $1.52M $1.52M Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Alia Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Alia Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of gene-editing therapies designed to address genetic diseases. The company utilizes a proprietary prediction
Drug Discovery
Pergine Valsugana, Italy
10 As of 2026

Beijing, China
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Alia Therapeutics Competitors (86)

One of Alia Therapeutics’s 86 competitors is EdiGene, a Venture Capital-Backed company based in Beijing, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
EdiGene Venture Capital-Backed Beijing, China
Editas Medicine Formerly VC-backed Cambridge, MA
iBio Corporation San Diego, CA
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
CRISPR Therapeutics Formerly VC-backed Zug, Switzerland
You’re viewing 5 of 86 competitors. Get the full list »

Alia Therapeutics Patents

  • 34

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 7

    Pending

  • Expiring in next 12 mo

Alia Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025252070-A1 Type v cas proteins and applications thereof Pending 04-Apr-2024
US-12480141-B2 Type v cas proteins and applications thereof Active 04-Apr-2024
US-20250313864-A1 Type v cas proteins and applications thereof Active 04-Apr-2024
WO-2025210147-A1 Type v cas proteins and applications thereof Pending 04-Apr-2024
WO-2025021702-A1 Cas9 orthologue nuclease and uses thereof Inactive 21-Jul-2023 C12N9/22
To view Alia Therapeutics’s complete patent history, request access »

Alia Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alia Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Banca Profilo Asset Manager Minority
Banor Sim Family Office Minority
Indaco Venture Partners Venture Capital Minority
Sofinnova Partners Venture Capital Minority
BiovelocITA Accelerator/Incubator Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Alia Therapeutics FAQs

  • When was Alia Therapeutics founded?

    Alia Therapeutics was founded in 2018.

  • Where is Alia Therapeutics headquartered?

    Alia Therapeutics is headquartered in Pergine Valsugana, Italy.

  • What is the size of Alia Therapeutics?

    Alia Therapeutics has 10 total employees.

  • What industry is Alia Therapeutics in?

    Alia Therapeutics’s primary industry is Drug Discovery.

  • Is Alia Therapeutics a private or public company?

    Alia Therapeutics is a Private company.

  • What is the current valuation of Alia Therapeutics?

    The current valuation of Alia Therapeutics is .

  • What is Alia Therapeutics’s current revenue?

    The current revenue for Alia Therapeutics is .

  • How much funding has Alia Therapeutics raised over time?

    Alia Therapeutics has raised $6.42M.

  • Who are Alia Therapeutics’s investors?

    Banca Profilo, Banor Sim, Indaco Venture Partners, Sofinnova Partners, and BiovelocITA are 5 of 7 investors who have invested in Alia Therapeutics.

  • Who are Alia Therapeutics’s competitors?

    EdiGene, Editas Medicine, iBio, Adaptimmune Therapeutics, and CRISPR Therapeutics are some of the 86 competitors of Alia Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process